Abstract

Background: Chemoradiation is the standard treatment for locally-advanced cervical cancer. Neoadjuvant chemotherapy is an alternative, with a 14% absolute improvement in survival, especially when intense and short. Methods: Since 2006, 83 patients were enrolled in this multicentric prospective phase II study. Eligibility criteria: squamous or adenosquamous cervical carcer; stages IB2, IIA, IIB; ECOG PS≤2; neutrophils ≥1,500 /μL; platelets ≥100,000/μL, normal renal and liver function. Treatment consisted of 6 weekly courses of Topotecan (2 mg/m2) and Cisplatin (40 mg/m2). All responsive and stable patients were submitted to radical surgery, while progressed underwent definitive radiotherapy±chemotherapy. Primary endpoint was evaluation of efficacy and toxicity . Results: Mean age was 48 years. Clinical FIGO Stage: 25 IB2; 11 IIA; 47 IIB. Suspicious lymph nodes at MRI were 35%. Ninety-six percent of patients received 6 courses, 98% of cycles were delivered at a full dose, without any delay in 96%. Treatment was well tolerated, no death occurred. G3-G4 bone marrow toxicity was observed in 4% of cycles. Clinical response rate was 81%. Five progressive cases and 3 partial responses with severe co-morbidities were treated with radiotherapy±chemotherapy, the others underwent radical surgery. Overall pathological response rate was 64%, with 25% of optimal responses. Nodal metastases occurred in 37% of patients. Forty-four percent of patients received adjuvant therapy because of negative prognostic factors. Mean follow-up is 20 months, 84% of patients are free from recurrence, 18% relapsed and 4% died. Conclusions: Weekly Topotecan and Cisplatin showed an acceptable toxicity and a promising response rate.

Autore Pugliese

• Cormio Gennaro

Tutti gli autori

• CORMIO G.

Titolo volume/Rivista

Non Disponibile

Anno di pubblicazione

2011

ISSN

Non Disponibile

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile